sulfasalazine has been researched along with Elevated ICP (Intracranial Pressure) in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Excerpt | Relevance | Reference |
---|---|---|
"Early diagnosis of intracranial hypertension is important in patients with ulcerative colitis receiving 5 ASA treatment to prevent visual complications." | 1.35 | Drug induced intracranial hypertension associated with sulphasalazine treatment. ( Kansu, T; Sevgi, E; Varli, K; Yalcin, G, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sevgi, E | 1 |
Yalcin, G | 1 |
Kansu, T | 1 |
Varli, K | 1 |
1 other study available for sulfasalazine and Elevated ICP (Intracranial Pressure)
Article | Year |
---|---|
Drug induced intracranial hypertension associated with sulphasalazine treatment.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Headache; Humans; Intra | 2008 |